Roy E Strowd 3rd Inas A Abuali Stuart A Grossman
10.2217/cns.15.3
CNS Oncol
2015;4(3):131-5.
cns lymphoma indolent lymphoma intrathecal rituximab low-grade lymphoma
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/25905905/
Antineoplastic Agents / therapeutic use Central Nervous System Neoplasms / cerebrospinal fluid Central Nervous System Neoplasms / drug therapy Lymphoma / cerebrospinal fluid Lymphoma / drug therapy Rituximab / therapeutic use
Antineoplastic Agents / therapeutic use Central Nervous System Neoplasms / cerebrospinal fluid Central Nervous System Neoplasms / drug therapy Lymphoma / cerebrospinal fluid Lymphoma / drug therapy Rituximab / therapeutic use Case Reports Aged Humans Male Neoplasm Recurrence, Local Antineoplastic Agents Rituximab
PMC4778415
25905905
Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma
2015